| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/01/2011 | CA2320116C 2-aminoquinoline derivatives having d4-agonistic activity |
| 02/01/2011 | CA2315717C Inhibition of raf kinase using substituted heterocyclic ureas |
| 02/01/2011 | CA2315713C Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 01/27/2011 | WO2011011522A2 Potent small molecule inhibitors of autophagy, and methods of use thereof |
| 01/27/2011 | WO2011010840A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/27/2011 | WO2011010839A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/27/2011 | WO2011010132A1 Sustained-release composition comprising compound 600 |
| 01/27/2011 | WO2011010083A1 Indolyl-pyridone derivatives |
| 01/27/2011 | WO2011009814A1 Compounds suitable for use as actinide ligands, synthesis and uses thereof |
| 01/27/2011 | WO2011009484A1 Arylpyrazoles and arylisoxazoles and their use as pkd modulators |
| 01/27/2011 | WO2010133976A3 Substantially pure imatinib or a pharmaceutically acceptable salt thereof |
| 01/27/2011 | WO2010130767A3 Fungicide pyrazole carboxamides derivatives |
| 01/27/2011 | WO2010118063A3 Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use |
| 01/27/2011 | WO2010104324A3 Halogenated isoindole compounds with superior binding affinity to beta-amyloid aggregates and fibrils, method for preparing same, and use thereof |
| 01/27/2011 | WO2009147626A3 Anhydrous amorphous form of imatinib mesylate |
| 01/27/2011 | WO2008087665A3 Process for preparation of lansoprazole |
| 01/27/2011 | US20110021782 Novel alkoxy enones and enamino ketones and a process for preparation thereof |
| 01/27/2011 | US20110021774 Method for producing pyrimidine compound |
| 01/27/2011 | US20110021771 Inhibitors of histone deacetylase |
| 01/27/2011 | US20110021574 Anti-cancer compounds, synthesis thereof, and methods of using same |
| 01/27/2011 | US20110021572 Fungicide hydroximoyl-tetrazole derivatives |
| 01/27/2011 | US20110021571 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 01/27/2011 | US20110021570 Pyridone glucokinase activators |
| 01/27/2011 | US20110021568 Tubulysin d analogues |
| 01/27/2011 | US20110021567 Preparation of lenalidomide |
| 01/27/2011 | US20110021565 Piperidine derivatives as nk3 antagonists |
| 01/27/2011 | US20110021557 Deuterium-enriched pyridinonecarboxamides and derivatives |
| 01/27/2011 | US20110021556 Pyrrolidinyl derivatives and uses thereof |
| 01/27/2011 | US20110021548 Inhibitors of malt1 proteolytic activity and uses thereof |
| 01/27/2011 | US20110021536 Crystalline Forms and Two Solvated Forms of 4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one Lactic Acid Salts |
| 01/27/2011 | US20110021532 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/27/2011 | US20110021528 Novel hydroxamates as therapeutic agents |
| 01/27/2011 | US20110021506 Anthelmintic agents and their use |
| 01/27/2011 | US20110021498 Indolyl- pyridone derivatives having checkpoint kinase 1 inhibitory activity |
| 01/27/2011 | US20110021495 Quinazoles useful as modulators of ion channels |
| 01/27/2011 | US20110021491 Compounds, pharmaceutical composition and methods relating thereto |
| 01/27/2011 | US20110021490 Chromene compounds, a process for their preparationand pharmaceutical compositions containing them |
| 01/27/2011 | US20110021489 Substituted piperidines |
| 01/27/2011 | US20110021488 New Compounds |
| 01/27/2011 | US20110021487 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their use |
| 01/27/2011 | US20110021486 Viral polymerase inhibitors |
| 01/27/2011 | US20110021462 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 01/27/2011 | US20110021407 Use of metal complex compounds as oxidation catalysts |
| 01/27/2011 | US20110020460 Gpr 119 modulators |
| 01/27/2011 | US20110017908 Dicationic liquid salts and methods of use thereof |
| 01/27/2011 | US20110016642 Dye composition comprising at least one colorless disulfide/thiol precursor, and dyeing process using the composition |
| 01/27/2011 | CA2768832A1 Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators |
| 01/27/2011 | CA2767772A1 Potent small molecule inhibitors of autophagy, and methods of use thereof |
| 01/26/2011 | EP2277877A1 Quinazoline derivatives as kinase inhibitors |
| 01/26/2011 | EP2277876A1 Substituted pyrimidines for the treatment of cancer |
| 01/26/2011 | EP2277875A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 01/26/2011 | EP2277867A2 Compounds, pharmaceutical compositions thereof and their use in treating cancer |
| 01/26/2011 | EP2277865A1 Phenyl-substituted 6-ring nitrogen-heterocycles as microtubule polymerisation inhibitors |
| 01/26/2011 | EP2277862A2 5-hydroxy-4-aminomethyl-1-cyclohexane or (cycloheptyl)--3-alkoxycarbonyl indole derivatives, pharmaceutically acceptable antiviral salts thereof and a method for the production thereof |
| 01/26/2011 | EP2277858A1 Amide compound |
| 01/26/2011 | EP2276761A1 Carboxamide compounds for the treatment of metabolic disorders |
| 01/26/2011 | EP2276756A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 01/26/2011 | EP2276750A2 Substituted pyrimidines and triazines and their use in cancer therapy |
| 01/26/2011 | EP2276748A1 Bicyclic nitrogen containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
| 01/26/2011 | EP2276747A1 Sulfonamides as zap-70 inhibitors |
| 01/26/2011 | EP2276746A1 Substituted pyridazinylmethyl sulfonamides |
| 01/26/2011 | EP2276744A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof |
| 01/26/2011 | EP2276741A1 Isoquinolinone derivatives as nk3 antagonists |
| 01/26/2011 | EP2276738A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 01/26/2011 | EP2276737A1 4- [3- (aryloxy) benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors |
| 01/26/2011 | EP2276736A1 4- [3- (aryloxy) benzyliden]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 01/26/2011 | EP2276735A1 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors |
| 01/26/2011 | EP2276734A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors |
| 01/26/2011 | EP2276732A1 Novel estrogen receptor ligands |
| 01/26/2011 | EP2276730A2 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/26/2011 | EP2276345A1 Small-molecule inhibitors of the androgen receptor |
| 01/26/2011 | EP2203439B1 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones |
| 01/26/2011 | EP2144894B1 Oxime ester photoinitiators |
| 01/26/2011 | EP2079726B1 Substituted amides, method of making, and method of use thereof |
| 01/26/2011 | EP2049515B1 Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of atherosclerosis |
| 01/26/2011 | EP2049514B1 Nitrate esters of piperidines |
| 01/26/2011 | EP2019825B9 Inhibitors of human immunodeficiency virus replication |
| 01/26/2011 | EP1973888B1 Isoxazolines for controlling invertebrate pests |
| 01/26/2011 | EP1948616B1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| 01/26/2011 | EP1919898B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/26/2011 | EP1831173B1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 01/26/2011 | EP1572660B1 Isoquinolinone derivatives and their use as therapeutic agents |
| 01/26/2011 | EP1554239B1 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
| 01/26/2011 | EP1496892B1 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/26/2011 | EP1489080B1 Process for producing cilostazol |
| 01/26/2011 | CN1918128B Fused ring 4-oxopyrimidine derivative |
| 01/26/2011 | CN1726603B Charge transport compositions and electronic devices made with such compositions |
| 01/26/2011 | CN101959882A 咪唑羰基化合物 Imidazole-carbonyl compound |
| 01/26/2011 | CN101959878A Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 01/26/2011 | CN101959877A Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/26/2011 | CN101959876A 2-aminoquinolines |
| 01/26/2011 | CN101959866A Novel 1-benzyl-3-hydroxymethyilindazole derivatives and use thereof in the treatment of diseases based on the expression MCP-1 and CX3CR1 |
| 01/26/2011 | CN101959865A Quinolines as inhibitors of farnesyl pyrophosphate synthase |
| 01/26/2011 | CN101959864A 2-aminoquinoline derivatives |
| 01/26/2011 | CN101959857A Compound for organic electroluminescent device and organic electroluminescent device using the same |
| 01/26/2011 | CN101959427A Flavor molecules |
| 01/26/2011 | CN101955494A Metal complexes of N-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 01/26/2011 | CN101955470A Potentiators of glutamate receptors |
| 01/26/2011 | CN101077875B Boronic ester and acid compounds, synthesis and uses |
| 01/26/2011 | CN101058561B Diphenylurea derivative for inhibiting protein kinase, and composition and use thereof |